Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 8Unknown 1Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma 25Small Cell Lung Carcinoma 23Leukemia 18Lymphoma, Large B-Cell, Diffuse 17Lung Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Non-Hodgkin 14Lymphoma, Extranodal NK-T-Cell 11Hodgkin Disease 10Leukemia, Myeloid, Acute 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 7Neuroblastoma 7Lymphoma, Mantle-Cell 7Burkitt Lymphoma 7Recurrence 6Lymphoma, T-Cell, Peripheral 6Central Nervous System Neoplasms 6Retinoblastoma 5Lymphoma, Large-Cell, Immunoblastic 5Lymphohistiocytosis, Hemophagocytic 5Breast Neoplasms 5Testicular Neoplasms 4Multiple Myeloma 4Lymphoma, Follicular 4Leukemia, Myelomonocytic, Acute 4Leukemia, Monocytic, Acute 4Leukemia, Megakaryoblastic, Acute 4Leukemia, Erythroblastic, Acute 4Teratoma 3

Interventions

Amifostine 4Cisplatin 3Voriconazole 2Radiotherapy 2Paclitaxel 2Methotrexate 2Drug Therapy 2selinexor 1sargramostim 1pazopanib 1lometrexol 1icotinib 1glucarpidase 1camrelizumab 1bismuth tripotassium dicitrate 1apatinib 1Telbivudine 1Surgical Procedures, Operative 1Pregabalin 1Pharmaceutical Preparations 1Ofloxacin 1Nivolumab 1Metronidazole 1Levofloxacin 1Imatinib Mesylate 1Hyperthermic Intraperitoneal Chemotherapy 1Gefitinib 1Folic Acid 1Etoposide 1Esomeprazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Drug-Related Side Effects and Adverse Reactions × Etoposide × Clear all
NCT00003583 2013-12-04

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
20 enrolled
Thoracic

Lung Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡